Glenmark Pharma.

Glenmark Pharmaceuticals Ltd Key Ratios

NSEBSE

₹1,615.6

(1.03%)

Jun 10, 2025|12:00:00 AM

Invest wise with Expert advice

QUICKLINKS FOR Glenmark Pharmaceuticals Ltd

ConsolidatedStandalone

GraphTable

Y/e 31 Mar	Mar-2021	Mar-2020	Mar-2018	Mar-2017
Growth matrix (%)
Revenue growth	2.84	17.26	-0.05	20.07
Op profit growth	22.74	5.12	-20.68	41.71
EBIT growth	17.39	2.53	-22.36	47.98
Net profit growth	25.01	-3.47	-27.49	49.21
Profitability ratios (%)
OPM	19.04	15.95	17.8	22.43
EBIT margin	15.45	13.53	15.48	19.93
Net profit margin	8.86	7.29	8.85	12.21
RoCE	14.29	13.41	14.28	20.93
RoNW	3.69	3.45	4.16	6.82
RoA	2.04	1.8	2.04	3.2
Per share ratios (₹)
EPS	34.38	27.5	28.49	39.29
Dividend per share	2.5	2.5	2	2
Cash EPS	18.66	12.71	17.79	29.92
Book value per share	250.36	215.13	182.99	159.21
Valuation ratios
P/E	13.51	7.49	18.5	21.83
P/CEPS	24.89	16.2	29.63	28.66
P/B	1.85	0.95	2.88	5.38
EV/EBIDTA	7.94	5.15	10.7	13.43
Payout (%)
Dividend payout	0	0	7.02	5.08
Tax payout	-30.82	-30.1	-28.18	-24.33
Liquidity ratios
Debtor days	83.06	81.3	95.25	98.43
Inventory days	73.58	71.45	83.85	74.5
Creditor days	-90.57	-82.83	-92.71	-98.99
Leverage ratios
Interest coverage	-4.78	-3.81	-4.91	-7.62
Net debt / equity	0.54	0.61	0.65	0.81
Net debt / op. profit	1.84	2.21	2.1	1.79
Cost breakup (₹)
Material costs	-33.79	-34.75	-33.48	-28.79
Employee costs	-21.41	-21.18	-20.62	-18.07
Other costs	-25.74	-28.09	-28.08	-30.7